109 related articles for article (PubMed ID: 38827434)
1. Correction to: "Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia".
JCEM Case Rep; 2024 Jun; 2(6):luae111. PubMed ID: 38827434
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia.
Sharma J; Kasliwal R; Jain T; Sharma GK
JCEM Case Rep; 2024 May; 2(5):luae044. PubMed ID: 38660485
[TBL] [Abstract][Full Text] [Related]
3. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficiency of
He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
[TBL] [Abstract][Full Text] [Related]
7. Successful Management Of Tumor-Induced Osteomalacia with Radiofrequency Ablation: A Case Series.
Mishra SK; Kuchay MS; Sen IB; Garg A; Baijal SS; Mithal A
JBMR Plus; 2019 Jul; 3(7):e10178. PubMed ID: 31372587
[TBL] [Abstract][Full Text] [Related]
8. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diagnostic efficacy of
Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
11. Role of Ga-68 DOTANOC Positron Emission Tomography/ Computed Tomography Scan in Clinical Management of Patients with Neuroendocrine Tumors and its Correlation with Conventional Imaging- Experience in a Tertiary Care Center in India.
Singh D; Arya A; Agarwal A; Agarwal G; Ravina M; Gambhir S
Indian J Nucl Med; 2022; 37(1):29-36. PubMed ID: 35478677
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation.
Tutton S; Olson E; King D; Shaker JL
J Clin Endocrinol Metab; 2012 Oct; 97(10):3421-5. PubMed ID: 22837186
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic values of
Kumar R; Vankadari K; Mittal BR; Bansal D; Trehan A; Sahu JK; Sankhyan N
Eur Radiol; 2021 Jul; 31(7):4587-4594. PubMed ID: 33409780
[TBL] [Abstract][Full Text] [Related]
14. Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review.
Xian MF; Pan KM; Zhang JC; Cheng MQ; Huang H; Chen LD; Zhao ZX; Wang W
Clin Hemorheol Microcirc; 2021; 77(1):61-69. PubMed ID: 32924995
[TBL] [Abstract][Full Text] [Related]
15.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
[TBL] [Abstract][Full Text] [Related]
17. Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT.
Naswa N; Sharma P; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2013 Aug; 38(8):639-40. PubMed ID: 23531775
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings.
Naswa N; Sharma P; Soundararajan R; Karunanithi S; Nazar AH; Kumar R; Malhotra A; Bal C
Abdom Imaging; 2013 Jun; 38(3):552-60. PubMed ID: 22743840
[TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
20. Correction to Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
Br J Radiol; 2017 Nov; 90(1079):20160811e. PubMed ID: 29034744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
